期刊文献+

抗呼吸道合胞病毒融合蛋白单链抗体的筛选及初步鉴定

Isolation of Human Single Chain Antibody against Fusion Protein of Human Respiratory Syncytial Virus
原文传递
导出
摘要 目的:从大容量噬菌体抗体库中筛选人源性抗呼吸道合胞病毒F蛋白的单链抗体。方法:以RSV F蛋白为靶抗原,通过"吸附-洗涤-洗脱-扩增"过程从天然人源性噬菌体抗体库中筛选特异性抗F蛋白单链抗体。5轮筛选后,单克隆经ELISA检测,阳性克隆进行核酸序列分析,并将阳性克隆噬菌体感染E.coliHB2151,经IPTG诱导,制备抗RSV F蛋白的可溶性单链抗体,并进行Western blot及Dot blot分析。结果:经过筛选,获得了18株能与F蛋白特异性结合的阳性克隆,取OD值最高的克隆E4经测序并检索Kabat数据库分析,显示其基因与人免疫球蛋白可变区基因具有高度同源性,Western blot及Dot blot分析表明为单链抗体。结论:利用天然人源性噬菌体抗体库技术制备出高特异性的人源性抗RSV F蛋白单链抗体。 Objective: To obtain the human single chain antibody (scFv) against fusion protein of Respiratory Syncytial Virus. Methods:A naive library of phage display human scFv, genes of which were derived from peripheral blood lymphocytes (PBLs) of 10 healthy donors, was constructed and panned by F of RSV to select specific anti-RSV F scFv. After 5 rounds of panning, the activity of individual clone was examined by ELISA. The genes of positive clones were sequenced. Soluble scFv was prepared through infecting E. coli HB2151 with one of the positive phage clones. Results: After the panning, scFvs from 18 clones can bind F specifically by ELISA. DNA sequence analysis of the clone FA with the highest OD indicates that the variable region gene of the clone is highly homologous with human immunoglobulin gene family. The expression of scFv E4 has been confirmed by Western blot and Dot blot. Conclusion:The specific human anti-RSV F scFv has been prepared successfully by exploiting phage antibody library.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2009年第9期7-11,共5页 China Biotechnology
关键词 人呼吸道合胞病毒 F蛋白 噬菌体抗体库 单链抗体 Human respiratory syncytial virus Fusion glycoprotein Phage display library Single chain fragment variable
  • 相关文献

参考文献9

  • 1Glezen W P, Taber L H, Frank A L, et al. Risk of primary infection and reinfection with respiratory syneytial virus. Am J Dis Child, 1986, 140(6) :543 -546.
  • 2吕治林.儿童疫苗的现状与展望[J].国外医学(流行病学.传染病学分册),2000,27(1):36-39. 被引量:4
  • 3Smith G P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228(4705) : 1315 - 1317.
  • 4Ghildyal R, Ho A, Jans D A. Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol Rev, 2006, 30(5) : 692 -705.
  • 5Bruno S, Gunetti M, Gammaitoni L, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cell:Rapid and transient megakaryocyte reconstitution. Haematologica, 2003, 88(4) :379 -387.
  • 6Wu H, Pfarr D S, Johnsonv S, et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol,2007,368(3) :652-665.
  • 7Schmitza U, Versmold A, Kaufmann P, et al. Phage Display: A molecular tool for the generation of antibodies- A review. Placenta, 2000, 21:106-112.
  • 8Strachan G, McElhiney J, Drever M R, et al. Rapid selection of anti-hapten antibodies isolated from synthetic and semisynthetic antibody phage display libraries expressed in Escherichia coli. FEMS Microbiology Letters, 2002, 210:257 - 261.
  • 9Hoogenboom H R, Griffiths A D, Johnson K S, et al. Multisubunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res, 1991, 19:4133 -4137.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部